|
⚲
|
| Keyboard |
| Orloff John J
✚
|
|
|---|---|
| CIK # | 0001643941 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001643941] | |
| 4 | [0001643941] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Orloff John J | |
| Zenas BioPharma Inc | |
| Alexion Pharmaceuticals Inc | |
| Novelion Therapeutics Inc | |
| Aegerion Pharmaceuticals Inc | |
| Baxalta Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Zenas BioPharma Inc ZBIO
Stock Option (Right to Buy) · derivative
|
2025-06-10 | Grant | 18,500 | $0.00 | |
|
Zenas BioPharma Inc ZBIO
Stock Option (Right to Buy) · derivative
|
2024-09-12 | Grant | 18,500 | $0.00 | |
|
Alexion Pharmaceuticals Inc ALXN
Common Stock, par value $.0001 per share
|
2021-07-21 | Disposed to issuer | 146,511 | $0.00 | |
|
Alexion Pharmaceuticals Inc ALXN
Common Stock, par value $.0001 per share
|
2021-07-14 | Grant | 30,643 | $0.00 | |
|
Alexion Pharmaceuticals Inc ALXN
Common Stock, par value $.0001 per share
|
2021-07-14 | Grant | 29,501 | $0.00 | |
|
Alexion Pharmaceuticals Inc ALXN
Common Stock, par value $.0001 per share
|
2021-06-08 | Tax withheld | 1,957 | $177.00 | 346,389 |
|
Alexion Pharmaceuticals Inc ALXN
Common Stock, par value $.0001 per share
|
2021-02-28 | Grant | 24,473 | $0.00 | |
|
Alexion Pharmaceuticals Inc ALXN
Common Stock, par value $.0001 per share
|
2020-12-16 | Tax withheld | 3,261 | $157.96 | 515,108 |
|
Alexion Pharmaceuticals Inc ALXN
Common Stock, par value $.0001 per share
|
2020-12-16 | Grant | 40,677 | $0.00 | |
|
Alexion Pharmaceuticals Inc ALXN
Common Stock, par value $.0001 per share
|
2020-12-16 | Tax withheld | 18,134 | $157.96 | 2,864,447 |
|
Alexion Pharmaceuticals Inc ALXN
Common Stock, par value $.0001 per share
|
2020-12-15 | Grant | 40 | $93.53 | 3,741 |
|
Alexion Pharmaceuticals Inc ALXN
Common Stock, par value $.0001 per share
|
2020-06-08 | Tax withheld | 2,784 | $114.61 | 319,074 |
|
Alexion Pharmaceuticals Inc ALXN
Common Stock, par value $.0001 per share
|
2020-03-02 | Tax withheld | 1,396 | $90.54 | 126,394 |
|
Alexion Pharmaceuticals Inc ALXN
Common Stock, par value $.0001 per share
|
2020-02-28 | Grant | 10,880 | $0.00 | |
|
Alexion Pharmaceuticals Inc ALXN
Common Stock, par value $.0001 per share
|
2019-12-15 | Grant | 38 | $93.86 | 3,567 |
|
Alexion Pharmaceuticals Inc ALXN
Common Stock, par value $.0001 per share
|
2019-06-07 | Tax withheld | 2,786 | $118.61 | 330,447 |
|
Alexion Pharmaceuticals Inc ALXN
Common Stock, par value $.0001 per share
|
2019-02-28 | Grant | 9,428 | $0.00 | |
|
Alexion Pharmaceuticals Inc ALXN
Common Stock, par value $.0001 per share
|
2019-02-28 | Tax withheld | 675 | $132.92 | 89,721 |
|
Alexion Pharmaceuticals Inc ALXN
Common Stock, par value $.0001 per share
|
2018-12-15 | Grant | 34 | $93.01 | 3,162 |
|
Novelion Therapeutics Inc NVLN
Stock Option (Right to Buy) · derivative
|
2018-08-09 | Grant | 10,000 | $0.00 | |
| showing 20 of 35 most recent transactions | |||||